Nate Raymond reports: A Georgia pediatric cardiologist pleaded guilty on Wednesday to wrongfully disclosing information about his young patients to an Aegerion Pharmaceuticals Inc sales representative seeking to identify potential new users of an expensive cholesterol drug. Dr. Eduardo Montana, 55, entered his plea in federal court in Boston after Aegerion, a unit of Novelion…
Category: Healthcare
Big pharma, big data: why drugmakers want your health records
Ben Hirschler reports: Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world. Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something…
De-identification of Data and Privacy
Cameron Abbott, Keely O’Dowd, and Giles Whittaker of K&L Gates write: As discussed in a recent blog post on CyberWatch Australia, researchers from the University of Melbourne successfully re-identified the medical data of Australian patients that formed part of a de-identified open dataset. This raises a myriad of questions about privacy, the need for access to big…
BlackBerry joins with Melanoma Institute Australia to trial secure research platform
One to watch. Lynne Minion reports: Better known for its mobile phones, once favoured by federal politicians and Kardashians, BlackBerry has spent years eking out a role as a global leader in the cybersecurity space. Now the brand is partnering with Melanoma Institute Australia to trial a secure data storage and collaboration platform to advance…